Analysts expect Phibro Animal Health Corporation (NASDAQ:PAHC) to report $0.36 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Phibro Animal Health Corporation’s earnings, with the highest EPS estimate coming in at $0.39 and the lowest estimate coming in at $0.33. Phibro Animal Health Corporation posted earnings of $0.40 per share during the same quarter last year, which suggests a negative year over year growth rate of 10%. The firm is expected to report its next quarterly earnings results after the market closes on Wednesday, August 30th.
On average, analysts expect that Phibro Animal Health Corporation will report full-year earnings of $1.45 per share for the current year. For the next financial year, analysts anticipate that the firm will report earnings of $1.56 per share, with EPS estimates ranging from $1.45 to $1.62. Zacks’ earnings per share averages are an average based on a survey of sell-side analysts that cover Phibro Animal Health Corporation.
Phibro Animal Health Corporation (NASDAQ:PAHC) last issued its earnings results on Monday, May 8th. The company reported $0.37 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.37. Phibro Animal Health Corporation had a net margin of 8.49% and a return on equity of 54.68%. The business had revenue of $190 million during the quarter, compared to analysts’ expectations of $185.90 million. During the same quarter in the prior year, the business posted $0.38 EPS. The company’s revenue for the quarter was up 3.5% on a year-over-year basis.
A number of research firms have recently weighed in on PAHC. Piper Jaffray Companies set a $35.00 price target on shares of Phibro Animal Health Corporation and gave the stock a “buy” rating in a research report on Friday, July 21st. BidaskClub raised shares of Phibro Animal Health Corporation from a “buy” rating to a “strong-buy” rating in a research report on Thursday, June 22nd. Credit Suisse Group downgraded shares of Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and raised their price target for the stock from $29.00 to $36.00 in a research report on Friday, June 2nd. Finally, Zacks Investment Research raised shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price objective for the company in a report on Thursday, May 11th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. Phibro Animal Health Corporation has an average rating of “Hold” and an average price target of $30.50.
Shares of Phibro Animal Health Corporation (NASDAQ PAHC) opened at 39.30 on Friday. Phibro Animal Health Corporation has a 52-week low of $20.14 and a 52-week high of $39.95. The stock has a market cap of $1.56 billion, a P/E ratio of 24.41 and a beta of 1.35. The company has a 50-day moving average of $37.96 and a 200 day moving average of $32.15.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 27th. Shareholders of record on Wednesday, September 6th will be issued a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a yield of 1.02%. The ex-dividend date of this dividend is Friday, September 1st. Phibro Animal Health Corporation’s dividend payout ratio is presently 24.69%.
ILLEGAL ACTIVITY NOTICE: This story was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another publication, it was illegally stolen and republished in violation of U.S. and international copyright legislation. The correct version of this story can be read at https://www.tickerreport.com/banking-finance/2801268/zacks-analysts-anticipate-phibro-animal-health-corporation-nasdaqpahc-will-announce-earnings-of-0-36-per-share.html.
In other news, major shareholder Bfi Co., Llc sold 48,000 shares of the business’s stock in a transaction on Thursday, June 15th. The shares were sold at an average price of $34.82, for a total transaction of $1,671,360.00. Following the completion of the transaction, the insider now owns 96,000 shares of the company’s stock, valued at $3,342,720. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Jack Bendheim sold 32,000 shares of the business’s stock in a transaction on Thursday, July 6th. The shares were sold at an average price of $36.49, for a total transaction of $1,167,680.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 352,000 shares of company stock valued at $12,599,200. 48.09% of the stock is currently owned by corporate insiders.
Several institutional investors have recently made changes to their positions in the stock. AJO LP purchased a new position in shares of Phibro Animal Health Corporation during the second quarter valued at about $5,815,000. Vanguard Group Inc. increased its position in shares of Phibro Animal Health Corporation by 8.2% in the first quarter. Vanguard Group Inc. now owns 1,729,406 shares of the company’s stock valued at $48,597,000 after buying an additional 130,935 shares during the period. Ameriprise Financial Inc. increased its position in shares of Phibro Animal Health Corporation by 50.6% in the second quarter. Ameriprise Financial Inc. now owns 339,996 shares of the company’s stock valued at $12,599,000 after buying an additional 114,230 shares during the period. Acadian Asset Management LLC increased its position in shares of Phibro Animal Health Corporation by 177.3% in the second quarter. Acadian Asset Management LLC now owns 129,060 shares of the company’s stock valued at $4,780,000 after buying an additional 82,524 shares during the period. Finally, Sit Investment Associates Inc. purchased a new position in shares of Phibro Animal Health Corporation during the first quarter valued at about $2,037,000. 47.41% of the stock is owned by institutional investors.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.